Cure Ventures

Massachusetts
Founded:2020
Firm Location:Massachusetts • Boston, Massachusetts • Cambridge, Massachusetts
Investor Firms That Co-Invest with Cure Ventures
Cure Ventures Team
Photo of Bill Amsbaugh, Partner at Cure Ventures
Bill Amsbaugh
Cure Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Photo of Milenko Cicmil, Partner at Cure Ventures
Milenko Cicmil
Cure Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of David Fallace, Managing Partner at Cure Ventures
David Fallace
Cure Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of May Han, Partner at Cure Ventures
May Han
Cure Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Photo of Drew King, Partner at Cure Ventures
Drew King
Cure Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Richard Lim, Managing Partner at Cure Ventures
Richard Lim
Cure Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists)
Photo of Kenzie Maclsaac, Partner at Cure Ventures
Kenzie Maclsaac
Cure Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Lou Tartaglia, Managing Partner at Cure Ventures
Lou Tartaglia
Cure Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A)
Photo of James Vath, Partner at Cure Ventures
James Vath
Cure Ventures·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists)